Top10 Drugs

 

藥品名

成分名

公司

治療疾病/適應症

2015 營收 (百萬美元)

核准日期

1

Humira

Adalimumab

AbbVie

Immunology       (Rheumatoid Arthritis (RA) etc. Total 9 indications)

14,012

Dec.31, 2002

2

Harvoni

Ledipasvir and Sofosbuvir

Gilead Sciences

Infectious Diseases (Hepatitis C)

13,864

Oct. 10, 2014

3

Enbrel

Etanercept

Amgen / Pfizer

Immunology       (Rheumatoid Arthritis (RA) etc. Total 5 indications)

8,697

Nov. 2, 1998

4

Remicade

Infliximab

Johnson & Johnson / Merck

Immunology       (Rheumatoid Arthritis (RA) etc. Total 8 indications)

8,355

Aug. 24, 1998

5

MabThera / Rituxan

Rituximab

Roche

Non–Hodgkin's Lymphoma (NHL), Chronic Lymphocytic Leukemia (CLL), Rheumatoid Arthritis (RA)

7,115

Nov. 26, 1997

6

Lantus

Insulin Glargine

Sanofi

Diabetes

7,029

Apr. 20, 2000

7

Avastin

Bevacizumab

Roche

Metastatic Colorectal Cancer (mCRC)

6,751

Feb. 26, 2004

8

Herceptin

Trastuzumab

Roche

Adjuvant Breast Cancer

6,603

Sep. 25, 1998

9

Revlimid

Lenalidomide

Celgene Corpoartion

Blood Related Disorders

5,801

Dec. 27, 2005

10

Sovaldi

Sofosbuvir

Gilead Sciences

Infectious Diseases (Hepatitis C)

5,276

Dec. 6, 2013

喜歡這篇文章嗎?立即分享

你可能感興趣的文章